Literature DB >> 17552903

Anti-innexin 2 aptamers specifically inhibit the heterologous interaction of the innexin 2 and innexin 3 carboxyl-termini in vitro.

Martin Knieps1, Sonja Herrmann, Corinna Lehmann, Birgit Löer, Michael Hoch, Michael Famulok.   

Abstract

We recently demonstrated that heteromerization of innexins 2 and 3 from Drosophila melanogaster (Dm) is crucial for epithelial organization and polarity of the embryonic epidermis. Both innexins are thought to interact via their C-terminal cytoplasmic domains during the assembly of heteromeric gap junction channels. However, the mechanisms that control heteromeric versus homomeric channel formation are still largely unknown. Here we report the isolation of both non-modified and 2'-fluoro-2'-deoxy-modified RNA anti-innexin 2 aptamers by in vitro selection. The aptamers bind to a proximal epitope on the carboxyl-tail of Dm innexin 2 protein and specifically inhibit the heterologous interaction of innexin 2 and innexin 3 carboxyl-termini in vitro. These domain-specific inhibitors represent the first step towards functional studies focusing on the activity of these domains in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17552903     DOI: 10.1515/BC.2007.074

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  3 in total

1.  Gap junctions in the ovary of Drosophila melanogaster: localization of innexins 1, 2, 3 and 4 and evidence for intercellular communication via innexin-2 containing channels.

Authors:  Johannes Bohrmann; Jennifer Zimmermann
Journal:  BMC Dev Biol       Date:  2008-11-27       Impact factor: 1.978

Review 2.  Gap junctions and hemichannels composed of connexins: potential therapeutic targets for neurodegenerative diseases.

Authors:  Hideyuki Takeuchi; Akio Suzumura
Journal:  Front Cell Neurosci       Date:  2014-09-02       Impact factor: 5.505

Review 3.  Innexins: Expression, Regulation, and Functions.

Authors:  Juan Güiza; Iván Barría; Juan C Sáez; José L Vega
Journal:  Front Physiol       Date:  2018-10-11       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.